Active Ingredient: Retatrutide Retatrutide is an experimental triple receptor agonistactivating GLP-1, GIP, and glucagon receptors designed to enhance weight loss and metabolic control
36 GLP-1R GLP-1R, a member of the GPCR family, exhibits specific affinity for GLP-1
Retatrutide Dosage Titration Schedule Note: This schedule is a general clinical model and may vary by patient
Avoid freezing reconstituted solution as this damages peptide structure
Where Ozempic could be beneficial is by helping to lower blood sugar and promote weight loss, which in turn would put less of a burden on the kidneys and support good kidney health over the long run. Dr
What the trials show Key trial programs anchor the evidence: STEP evaluated semaglutide for weight management ( The New England Journal of Medicine , 2021), SURMOUNT evaluated tirzepatide for weight management (NEJM 2022), and SURMOUNT-OSA evaluated tirzepatide for obstructive sleep apnea (NEJM 2024)